Delivery Order SPE2DB25D9305-SPE2DB26FQAAK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,534.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in the open market. This delivery order is...
- The Defense Logistics Agency awarded a $3,727.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- The Defense Logistics Agency awarded a $14,822.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. The delivery order, which must be completed by October 16, 2025, is for the supply of Photrexa Cross-Linking Kit (6ml), a specialized pharmaceutical product. This award was made without a set-aside designation, reflecting the company's competitive standing in the federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,727.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PHOTREXA Cross-Linking Kit 6ML. This firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of September 2, 2025, with no set-aside designation applied. The product will be delivered to Park Ridge, IL, where the vendor is headquartered. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,560.30 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ML, a pharmaceutical product. This firm fixed-price delivery order, issued on October 8, 2025, is scheduled for completion by October 30, 2025, with performance taking place in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $7,455.02 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to provide this pharmaceutical product with a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 10, 2025, and was awarded on June 17, 2025, with no set-aside...
- The Defense Logistics Agency has awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Photrexa Cross-Linking Kit 6ml. This delivery order, issued on August 22, 2025, carries a firm fixed price and an ultimate completion date of September 15, 2025. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the...
- The Defense Logistics Agency awarded a $18,637.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform this delivery order at its Park Ridge, IL location, continuing its...
- The Defense Logistics Agency (DLA) awarded a $7,455.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- SPE2DB25D9305Indefinite Delivery Contract
- SPE2DB25D9305-SPE2DB26FQAAKDelivery Order
The Defense Logistics Agency awarded a $8,280.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, was executed without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. Performance will take place at the awardee's Park Ridge facility, with no subcontractors identified in the award documentation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion governmentwide acquisition strategy. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and enables DLA to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous delivery orders under this vehicle demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 10/21/25 |